Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Convatec Group Plc | LSE:CTEC | London | Ordinary Share | GB00BD3VFW73 | ORD 10P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.20 | 0.09% | 233.20 | 83,015 | 08:56:16 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 233.00 | 233.40 | 235.40 | 232.40 | 233.20 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Med, Dental, Hosp Eq-whsl | USD 2.14B | USD 130.3M | USD 0.0636 | 36.57 | 4.78B |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 08:56:13 | O | 423 | 233.20 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 15/11/2024 | 11:53 | UK RNS | Convatec Group PLC Holding(s) in Company |
| 14/11/2024 | 20:01 | ALNC |  Convatec expresses disappointment at InnovaMatrix Medicare exclusion |
| 14/11/2024 | 17:52 | UK RNS | Convatec Group PLC Convatec responds to LCDs in the United States |
| 12/11/2024 | 11:40 | ALNC | EXTRA: Convatec's strong trading reassures amid InnovaMatrix concern |
| 12/11/2024 | 09:33 | ALNC | TOP NEWS: Bullish Convatec lifts guidance and predicts further growth |
| 12/11/2024 | 07:00 | UK RNS | Convatec Group PLC Trading update for 10 months ended 31 October 2024 |
| 06/11/2024 | 09:00 | UK RNS | Convatec Group PLC Holding(s) in Company |
| 15/10/2024 | 08:45 | UK RNS | Convatec Group PLC Holding(s) in Company |
| 19/8/2024 | 14:17 | UK RNS | Convatec Group PLC Notification of Major Holdings |
| 02/8/2024 | 13:39 | UK RNS | Convatec Group PLC Holdings in Company |
Convatec (CTEC) Share Charts1 Year Convatec Chart |
|
1 Month Convatec Chart |
Intraday Convatec Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 08/3/2024 | 12:29 | ConvaTec - placing at 225p | 391 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 08:56:13 | 233.20 | 423 | 986.44 | O |
| 08:56:13 | 233.20 | 1,099 | 2,562.87 | AT |
| 08:56:13 | 233.20 | 1,600 | 3,731.20 | AT |
| 08:56:13 | 233.20 | 7 | 16.32 | AT |
| 08:46:40 | 233.20 | 556 | 1,296.59 | AT |
| Top Posts |
|---|
Posted at 21/11/2024 08:20 by Convatec Daily Update Convatec Group Plc is listed in the Med, Dental, Hosp Eq-whsl sector of the London Stock Exchange with ticker CTEC. The last closing price for Convatec was 233p.Convatec currently has 2,049,789,559 shares in issue. The market capitalisation of Convatec is £4,767,810,514. Convatec has a price to earnings ratio (PE ratio) of 36.57. This morning CTEC shares opened at 233.20p |
Posted at 12/5/2022 16:38 by km18 ConvaTec Group plc issued an AGM trading update for the four months ended 30 April 2022 this morning. Group revenue increased by 4.1% on a reported basis, up 7.5% on a constant currency basis and up 6.0% on an organic basis. ConvaTec has made a good start to the year with good underlying growth in each of its four categories in line with expectations. ConvaTec also announced that it will be withdrawing from its hospital care activities and related industrial sales during the remainder of 2022. These low margin activities being exited generated $ 101 m of revenue in 2021. Given this phased exit of the hospital care and related industrial sales products, reported revenue in 2022 is expected to be approximately $ 20-30 m lower than 2021 and adjusted EBIT is expected to reduce by $3-5m. There is also expected to be a one-off adjusted P&L charge of approximately $55m, which will be incurred in 2022, and a cash cost of approximately $25m arising mainly in 2022. FY22 guidance is unchanged, management expect organic revenue growth of between 4.0% and 5.5% and a constant currency EBIT margin of at least 18%. Valuation is average, profitability is decent, growth relatively modest. The share price also lacks some momentum. CTEC is a share to monitor for now.......from WealthOracleAM |
Posted at 16/3/2021 20:46 by thewheeliedealer Hi all,My mate Peter @Conkers3 and myself did a ‘Twin Petes Investing’ Podcast last week and part of our discussion includes CTEC which we both see as a decent and solid Long-Term Hold kind of Stock. As always we also chatted about loads of other Stocks and Ideas for research and a fair bit of educational stuff with regards to Investing and Portfolio Management. Specific topics in this one include the risks of anonymous Twitter Accounts and the devious tricks the ‘owners’ get up to, and we give examples of our own Trades and how we have Scaled in and Scaled out etc. Anyway, if you use Youtube, Apple, Audioboom, Overcast, Google+ or Spotify you can find it under the 'Conkers Corner' Channel (you want Podcast TPI 44) and you can find it on Soundcloud at the link below. I hope you enjoy it and find it useful, we try to keep them light and they are totally unscripted, with the intent being that it is like you are eavesdropping on us having a chat down the local boozer (we can dream !!). Cheers, WD @wheeliedealer |
Posted at 23/12/2020 12:15 by robow CTEC is one of Shares magazine top picks for 2021. In brief - the business is looking healthier after rectifing earlier mistakes and earnings growth is back on the menu |
Posted at 31/5/2020 13:12 by doubleorquits Indeed, although I feel it may lose out to Kingfisher in the final furlong. The top four to replace the losers highlighted in The Observer are AVST,GVC,HSV and KGF at the moment although it is close between the latter and CTEC (I think all the others are safer bets). Review actually takes place at the close on Tuesday and changes become confirmed on Monday 22nd June.The following site is an excellent reference point for this: NB: All five might go in if ITV loses a bit more ground in the next three days. |
Posted at 31/5/2020 12:56 by hootstox Getting some coverage about FTSE100 changeover, CTEC could move up on Fridayhttps://www.th |
Posted at 12/5/2020 14:25 by brain smiley 120 million share placing today. |
Posted at 29/7/2019 11:58 by ny boy Gap to fill on the breakout to 188/190p areaConvaTec Group Plc shows strong development within a rising trend channel in the medium long term. Rising trends indicate that the company experiences positive development and that buy interest among investors is increasing. The price has had a strong fall after the negative signal from rectangle formation at the break down through the support at 188. The objective at 152 is now met, but the formation signals further development in the same direction. The stock has broken up through the resistance at pence 147. This predicts a further rise. In case of negative reactions, there will now be support at pence 147. The stock is overall assessed as technically positive for the medium long term. Recommendation one to six months: Positive |
Posted at 28/7/2019 12:27 by robow CTEC gets a mention in todays TimesConvatec could be a comfort in old age. 'there could be rewards ahead...BUY' |
Posted at 22/1/2019 10:08 by robow One of Peel Hunt's stock picks for 2019Convatec (CTEC) The depressed share price at medical products company Convatec has led to a rise in the dividend yield but the poor sentiment is unfounded. Analyst Amy Walker retained her ‘hold’ recommendation and target price of 170p on the stock. She said that ‘low visibility on earnings momentum has depressed the share price, leading to a rise in the dividend yield’ but even if the group misses her ‘conservative& Walker is not pessimistic about the outlook for the company, stating that the demand for the medical technology firm’s products were ‘unlikely to change materially from their mid-single digit market growth rates’. She added that the company can ‘support a stable to growing dividend’ but the most likely driver of volatility is the share price ‘which declined more than 30% on the most recent profit warning’. |
Posted at 30/10/2018 09:55 by philanderer Numis upgrades Convatec to ‘buy’Numis has upgraded medical technology company Convatec (CTEC) after an ‘unwarranted&r Analyst Paul Cuddon upgraded his recommendation from ‘hold’ to ‘buy’ with a target price of 220p on the shares, which jumped 5.6% to 155p yesterday. ‘We do not think the loss of a chief executive and the decline in infusion devices warranted a 35% fall in Convatec’s share price, especially when the broader chronic care business is maintaining consistent 2% quarterly growth,’ he said. ‘We see full-year 2018 results, details on the self-help strategy and full-year 2019 outlook as key catalysts. The company trades on 10x enterprise value/earnings and offering sector leading free cashflow yield and so we upgrade to “buy”.&r |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
